StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) stock

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$18.98−0.39 (-2.01%)

Close on Nov 18, 2026Market cap $912.15MP/E –Yield –

Odyssey Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Odyssey Therapeutics's market cap was $1.01B on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.01B–

More Odyssey Therapeutics figures

See a number that looks wrong?